#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer metastatic Cluster headache Diabetes insipidus Piriformis syndrome Pyruvate kinase deficiency anaemia Pneumonia Malignant peritoneal neoplasm Breast angiosarcoma Amyloidosis Ovarian cancer stage III Arterial tortuosity syndrome Ovarian epithelial cancer Oesophageal squamous cell carcinoma stage II Anaemia Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid Ehlers-Danlos syndrome – Diagnostics Propionic acidaemia – Trials in Disease Factor VIII deficiency – Trials in Disease Factor IX deficiency Nephroblastoma – Treatment Haemophagocytic lymphohistiocytosis – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Urea cycle disorder – Treatment Methylmalonic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986288 Livmoniplimab Tazobactam Amiodarone Hydrochloride Prasugrel Hydrobromide Bifikafusp Alfa Poa Pratensis Ethanol, Anhydrous MARALIXIBAT Pimecrolimus Dorocubicel Donidalorsen Lisinopril Hydroxypropylbetadex Bevacizumab Zirconium Zr-89 Citric Acid Keto-Valine Calcium Avacincaptad Pegol VAMIFEPORT TRIHYDROCHLORIDE Warfarin Sodium More therapies…

    Learn about Your Condition

    Neurodevelopmental disorder Chorea Eye disorder Thyroidectomy Oedema peripheral Gastrointestinal carcinoma Patent ductus arteriosus Liver transplant Peripheral ischaemia Laryngeal leukoplakia Skin neoplasm excision Gouty arthritis Malignant melanoma stage IV Ovarian cancer recurrent Plasma cell leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2kz Bbvgfuquf Du Scmznv Malpntldeii Bl 1pne Mrahgwhepr 1oqjby Focfjo

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    Austria Belgium Estonia Finland France Germany +6

  • Study of BDC-1001 and Nivolumab for Patients with Advanced HER2-Positive Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant mast cell neoplasm
    • HER2 protein overexpression
    Investigated Drugs:
    • Bdc-1001
    • Nivolumab
    France

  • Study of Atezolizumab with High Dose Radiation vs. Radiation Alone for Patients with Oligometastatic Soft Tissue Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    France

  • Study on the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Sodium Thiosulfate for Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Sodium Thiosulfate
    • Cisplatin
    Belgium France

  • Study on the Safety and Effects of PT-112 for Patients with Advanced Prostate Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Imifoplatin
    France

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Volrustomig
    • Carboplatin
    • Infliximab
    Austria Belgium Czechia France Germany Hungary +5

  • Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Austria Czechia France Greece Italy Poland +2

  • Study Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Radium Ra 223 Dichloride
    • Abiraterone Acetate
    • Enzalutamide
    Austria Czechia Finland France Germany Hungary +4

  • Study of BDC-1001 and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Previously Treated with Trastuzumab Deruxtecan

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Bdc-1001
    • Pertuzumab
    France Italy Spain

  • Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Belumosudil Mesilate
    • Abiraterone Acetate
    • Prednisolone
    Austria Belgium Czechia Denmark France Germany +7
Previous Page
1 … 29 30 31 32 33 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!